SCHEMBL147358

SCHEMBL147358

NC(=S)Nc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
MEN1 O00255 5/20 0.63
KMT2A Q03164 5/20 0.63
MAPT P10636 5/20 0.55
GAA P10253 3/20 0.55
NPC1 O15118 3/20 0.55
LMNA P02545 2/20 0.55
ALOX12 P18054 2/20 0.55
HTT P42858 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
TGM2 P21980 1/20 0.54
PKM P14618 1/20 0.54
HPGD P15428 1/20 0.54
KDM4E B2RXH2 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA9 Q16790 1/20 0.54
RAB9A P51151 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27499998 0.98 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL5528163 0.90 MEN1 (0.62) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL5527089 0.90 MAPT (0.69) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL16573282 0.85 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL14633632 0.84 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL6301912 0.84 ALDH1A1 (0.79) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL1102071 0.82 KMT2A (0.71) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL7776355 0.82 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL11075336 0.81 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL458335 0.81 ALDH1A1 (0.70) ALDH1A1SMN1; SMN2MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115819305-B Continuous preparation process of p-nitrophenyl thiourea 浙江迪邦化工有限公司 2024-06-07 CN claimed
CN-116804070-A Polyacrylamide polymer for movable gel, and preparation method and application thereof 中国石油化工股份有限公司 2023-09-26 CN claimed
CN-116514834-A Chiral alpha-CF 2 H spiro [ pyrrolidine-pyrazolones]Synthesis method of class compound 深圳市图微安创科技开发有限公司 2023-08-01 CN claimed
CN-115819305-A Continuous preparation process of p-nitrophenylthiourea 浙江迪邦化工有限公司 2023-03-21 CN claimed
EP-3830318-A1 ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY COVENTYA S.p.A. (IT) 2021-06-09 EP claimed
WO-2020025448-A1 ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY COVENTYA S.P.A. (IT) 2020-02-06 WO claimed
EP-3604626-A1 ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY COVENTYA S.p.A. (IT) 2020-02-05 EP claimed
CN-107056666-B A kind of organogel compound of 4- nitrobenzenes thiocarbamide and preparation method thereof, gel and application 信阳师范学院 2018-09-14 CN claimed
CN-107056666-A A kind of organogel compound of 4 nitrobenzene thiocarbamide and preparation method thereof, gel and application 信阳师范学院 2017-08-18 CN claimed
CN-103373969-A Phenyl imidazole ring-substituted amide compounds as well as preparation method and application for same SHANGHAI INST ORGANIC CHEM 2013-10-30 CN claimed
CN-102079732-B Method for synthesizing 2-amino-4-methylthiazole-5-carboxylate and derivatives thereof UNIV XI AN JIAOTONG 2013-03-13 CN claimed
CN-102079732-A Method for synthesizing 2-amino-4-methylthiazole-5-carboxylate and derivatives thereof UNIV XI AN JIAOTONG 2011-06-01 CN claimed
CN-101687816-A Triaminopyrimidine derivatives as the CDC25 inhibitors of phosphatases IPSEN PHARMA SAS 2010-03-31 CN claimed
CN-100360932-C Reagent for detecting mercury ion in water and its preparation method UNIV XIAMEN (CN) 2008-01-09 CN claimed
CN-1752750-A Reagent for detecting mercury ion in water and its preparation method UNIV XIAMEN (CN) 2006-03-29 CN claimed
EP-1148048-B1 Polyaromatic compounds for treating herpes viral infections PHARMACIA & UPJOHN CO LLC (US) 2005-06-29 EP claimed
US-5236633-A Blend of transparent polymer, thiourea and copper compounds JUJO PAPER CO., LTD. (JP) 1993-08-17 US claimed
US-4363913-A Preparation of 2-aminobenzothiazoles EASTMAN KODAK COMPANY (US) 1982-12-14 US claimed
US-4264710-A AN ETHYLENICALLY UNSATURATED COMPOUND, AND A PHOTOPOLYMERIZATION INIATOR FUJI PHOTO FILM CO., LTD. (JP) 1981-04-28 US claimed
CN-119390872-A P-nitrobenzoyl thiourea chitosan derivative and application thereof 新疆大学 2025-02-07 CN disclosed
CN-119390872-A P-nitrobenzoyl thiourea chitosan derivative and application thereof 新疆大学 2025-02-07 CN disclosed
CN-107629022-B Antibacterial synergist and preparation method and application thereof 上海医药工业研究院 2024-11-12 CN disclosed
CN-118619952-A Aloperine derivative, preparation method, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2024-09-10 CN disclosed
CN-115819305-B Continuous preparation process of p-nitrophenyl thiourea 浙江迪邦化工有限公司 2024-06-07 CN disclosed
CN-115819305-B Continuous preparation process of p-nitrophenyl thiourea 浙江迪邦化工有限公司 2024-06-07 CN disclosed
CN-115819305-B Continuous preparation process of p-nitrophenyl thiourea 浙江迪邦化工有限公司 2024-06-07 CN disclosed
US-11993573-B2 Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) 2024-05-28 US disclosed
EP-4333843-A1 BITHIAZOL DERATIVES AS INHIBITORS OF LYSYL OXIDASES University of South Carolina (US) 2024-03-13 EP disclosed
US-20240075015-A1 Inhibitors of Lysyl Oxidases UNIVERSITY OF SOUTH CAROLINA 2024-03-07 US disclosed
CN-117545480-A Dithiazole derivatives as inhibitors of lysyl oxidase 南卡罗来纳大学 2024-02-09 CN disclosed
CN-115109048-B (hetero) aryl amide compound 中国药科大学 2023-12-08 CN disclosed
CN-116804070-A Polyacrylamide polymer for movable gel, and preparation method and application thereof 中国石油化工股份有限公司 2023-09-26 CN disclosed
CN-116768770-A Diaryl thiourea compound and application thereof 上海交通大学医学院 2023-09-19 CN disclosed
CN-114249702-B N-aryl- [2,4 '-dithiazole ] -2' -amine compound and preparation and application thereof 沈阳药科大学 2023-09-05 CN disclosed
US-20230263167-A1 METHOD OF PREPARING A BISMUTH SULFIDE PARTICLE CONTAINING ANTIBACTERIAL COMPOSITION IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-08-24 US disclosed
US-11712437-B2 Inhibitors of lysyl oxidases UNIVERSITY OF SOUTH CAROLINA (US) 2023-08-01 US disclosed
US-11712437-B2 Inhibitors of lysyl oxidases UNIVERSITY OF SOUTH CAROLINA (US) 2023-08-01 US disclosed
US-11712437-B2 Inhibitors of lysyl oxidases UNIVERSITY OF SOUTH CAROLINA (US) 2023-08-01 US disclosed
CN-116514834-A Chiral alpha-CF 2 H spiro [ pyrrolidine-pyrazolones]Synthesis method of class compound 深圳市图微安创科技开发有限公司 2023-08-01 CN disclosed
US-11700855-B2 Method for preventing or reducing growth of a microorganism on a surface IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2023-07-18 US disclosed
WO-2023121022-A1 NOVEL LEUKOTRIENE B4 RECEPTOR INHIBITORS AND USE THEREOF 이화여자대학교 산학협력단 2023-06-29 WO disclosed
CN-111704620-B [3,2' ] -pyrrolidine chiral spiro oxindole skeleton compound, and preparation method and application thereof 中国科学院成都有机化学有限公司 2023-05-23 CN disclosed
US-20230129765-A1 METHOD FOR PRODUCING POLYTHIOETHER COMPOUND DAICEL CORPORATION (JP) 2023-04-27 US disclosed
CN-115819305-A Continuous preparation process of p-nitrophenylthiourea 浙江迪邦化工有限公司 2023-03-21 CN disclosed
CN-115819305-A Continuous preparation process of p-nitrophenylthiourea 浙江迪邦化工有限公司 2023-03-21 CN disclosed
CN-115819305-A Continuous preparation process of p-nitrophenylthiourea 浙江迪邦化工有限公司 2023-03-21 CN disclosed
EP-4108705-A1 METHOD FOR PRODUCING POLYTHIOETHER COMPOUND Daicel Corporation (JP) 2022-12-28 EP disclosed
US-20220378753-A1 NOVEL INHIBITORS OF LYSYL OXIDASES UNIVERSITY OF SOUTH CAROLINA (US) 2022-12-01 US disclosed
WO-2022240476-A1 BITHIAZOL DERATIVES AS INHIBITORS OF LYSYL OXIDASES UNIVERSITY OF SOUTH CAROLINA (US) 2022-11-17 WO disclosed
CN-115135697-A Process for producing polythioether compound 株式会社大赛璐 2022-09-30 CN disclosed
CN-114249702-A N-aryl- [2,4 '-bithiazole ] -2' -amine compound and preparation and application thereof 沈阳药科大学 2022-03-29 CN disclosed
CN-113278149-A Process for producing polythioether compound 株式会社大赛璐 2021-08-20 CN disclosed
EP-3830318-A1 ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY COVENTYA S.p.A. (IT) 2021-06-09 EP disclosed
US-20210061670-A1 METHOD FOR PREVENTING OR REDUCING GROWTH OF A MICROORGANISM ON A SURFACE IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2021-03-04 US disclosed
US-10934176-B2 Methods of degrading organic pollutants and preventing or treating microbe using Bi2S3-CdS particles IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2021-03-02 US disclosed
CN-211963342-U Filtration equipment of p-nitrothiosemicarbazide 杭州布朗生物医药科技有限公司 2020-11-20 CN disclosed
CN-111704620-A High-optical-purity [3, 2' ] -pyrrolidine chiral spiro-oxoindole skeleton compound, and preparation method and application thereof 中国科学院成都有机化学有限公司 2020-09-25 CN disclosed
US-20200102228-A1 METHODS OF DEGRADING ORGANIC POLLUTANTS AND PREVENTING OR TREATING MICROBE USING Bi2S3-CdS PARTICLES IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2020-04-02 US disclosed
WO-2020025448-A1 ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY COVENTYA S.P.A. (IT) 2020-02-06 WO disclosed
EP-3604626-A1 ELECTROPLATING BATH FOR DEPOSITING A BLACK ALLOY, METHOD FOR THE ELECTROCHEMICAL DEPOSITION OF A BLACK ALLOY ON A SUBSTRATE, A BLACK ALLOY AND AN ARTICLE COATED WITH SUCH BLACK ALLOY COVENTYA S.p.A. (IT) 2020-02-05 EP disclosed
CN-107963617-B A kind of production method and system of nitrosyl sulfuric acid ZHEJIANG DIBANG CHEMICAL CO., LTD. (CN) 2019-11-01 CN disclosed
CN-109971202-A A kind of benzothiazoles dispersion dyes monomer compound and its synthetic method and application 浙江迪邦化工有限公司 2019-07-05 CN disclosed
US-10105687-B1 Heterostructured Bi2S3—ZnS photocatalysts and methods thereof IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) 2018-10-23 US disclosed
CN-107056666-B A kind of organogel compound of 4- nitrobenzenes thiocarbamide and preparation method thereof, gel and application 信阳师范学院 2018-09-14 CN disclosed
CN-107056666-B A kind of organogel compound of 4- nitrobenzenes thiocarbamide and preparation method thereof, gel and application 信阳师范学院 2018-09-14 CN disclosed
CN-107056666-B A kind of organogel compound of 4- nitrobenzenes thiocarbamide and preparation method thereof, gel and application 信阳师范学院 2018-09-14 CN disclosed
CN-107963617-A The production method and system of a kind of nitrosyl sulfuric acid 浙江迪邦化工有限公司 2018-04-27 CN disclosed
CN-107056666-A A kind of organogel compound of 4 nitrobenzene thiocarbamide and preparation method thereof, gel and application 信阳师范学院 2017-08-18 CN disclosed
CN-107056666-A A kind of organogel compound of 4 nitrobenzene thiocarbamide and preparation method thereof, gel and application 信阳师范学院 2017-08-18 CN disclosed
EP-2700636-B1 PROCESS FOR PREPARING EPISULFIDE COMPOUNDS ASAHI CHEMICAL IND (JP) 2017-08-02 EP disclosed
US-20170020900-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF NIH - DEITR 2017-01-26 US disclosed
US-9359324-B2 Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-06-07 US disclosed
CN-105524013-A Preparation method of 4,5-disubstituted-2-substituted aminothiazole compound UNIV ZHEJIANG 2016-04-27 CN disclosed
US-9301940-B2 Methods for screening antimicrobial and antiviral compounds and uses thereof THE GENERAL HOSPITAL CORPORATION (US) 2016-04-05 US disclosed
US-9301940-B2 Methods for screening antimicrobial and antiviral compounds and uses thereof THE GENERAL HOSPITAL CORPORATION (US) 2016-04-05 US disclosed
US-9150561-B2 Thiazole derivatives and use thereof MERCK SERONO S.A. (CH) 2015-10-06 US disclosed
CN-103159695-B HIV can be suppressed to copy and to effective thiazole compound of resistance HIV virus strain and its production and use CAPITAL NORMAL UNIVERSITY (CN) 2015-08-12 CN disclosed
US-20150197501-A1 Process for Preparing Episulfide Compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-07-16 US disclosed
US-9051293-B2 Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-06-09 US disclosed
CN-104610222-A Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORP 2015-05-13 CN disclosed
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed
CN-102603726-B 5-(2-aminothiazole-4-yl) benzofuranol etheric compound with herbicidal activity and preparation method HUNAN RES INST CHEMICAL IND 2014-08-13 CN disclosed
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20140107350-A1 Process for Preparing Episulfide Compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-04-17 US disclosed
EP-2700636-A1 PROCESS FOR PREPARING EPISULFIDE COMPOUNDS Asahi Kasei Chemicals Corporation (JP) 2014-02-26 EP disclosed
CN-103476764-A Process for producing episulfide compound ASAHI KASEI CHEMICALS CORP (JP) 2013-12-25 CN disclosed
US-20130184258-A1 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-07-18 US disclosed
CN-103159695-A Thiazole compound capable of restraining human immunodeficiency virus (HIV) replication and effective against drug-resistant HIV virus strains and preparation method and purpose thereof UNIV CAPITAL NORMAL 2013-06-19 CN disclosed
CN-102079732-B Method for synthesizing 2-amino-4-methylthiazole-5-carboxylate and derivatives thereof UNIV XI AN JIAOTONG 2013-03-13 CN disclosed
US-8309543-B2 Compositions useful as inhibitors of voltage-gated sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-11-13 US disclosed
CN-101906083-B Method for preparing 2-amino-6-nitrobenzothiazole GUANGZHOU FANGDA SCIENCE AND TECHNOLOGY CO LTD 2012-10-03 CN disclosed
US-20120238578-A1 COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-09-20 US disclosed
CN-102603726-A 5-(2-aminothiazole-4-yl) benzofuranol etheric compound with herbicidal activity and preparation method HUNAN RES INST CHEMICAL IND 2012-07-25 CN disclosed
CN-102010406-B 4-(benzofuran-5-yl)-2-aromatic aminothiazole and preparation method and application thereof UNIV HUNAN 2012-07-04 CN disclosed
US-8202861-B2 Drugs for various disorders VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-19 US disclosed
CN-1926121-B Thiazole derivatives and uses thereof MERCK SERONO SA 2012-06-13 CN disclosed
US-8153655-B2 Compositions useful as inhibitors of voltage-gated sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
WO-2012038904-A1 NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-03-29 WO disclosed
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2012-03-08 US disclosed
EP-2332912-A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-15 EP disclosed
EP-2327701-A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-06-01 EP disclosed
CN-102079732-A Method for synthesizing 2-amino-4-methylthiazole-5-carboxylate and derivatives thereof UNIV XI AN JIAOTONG 2011-06-01 CN disclosed
US-20110105436-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT AUCKLAND UNISERVICES LIMITED (NZ) 2011-05-05 US disclosed
CN-102010406-A 4-(benzofuran-5-yl)-2-aromatic aminothiazole and preparation method and application thereof UNIV HUNAN 2011-04-13 CN disclosed
CN-101906083-A Method for preparing 2-amino-6-nitrobenzothiazole GUANGZHOU FANGDA SCIENCE AND TECHNOLOGY CO LTD 2010-12-08 CN disclosed
US-20100298340-A1 Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies ASTRAZENECA AB (SE) 2010-11-25 US disclosed
US-20100216852-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF THE GENERAL HOSPITAL CORPORATION 2010-08-26 US disclosed
US-20100216852-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF THE GENERAL HOSPITAL CORPORATION 2010-08-26 US disclosed
CN-101768134-A 2-imido-3-(substituted phenyl)-4-methyl-5-acetyl-4-thiazoline and synthesis method thereof ZHEJIANG PHARMACEUTICAL COLLEG 2010-07-07 CN disclosed
US-20100087479-A1 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-04-08 US disclosed
CN-101687816-A Triaminopyrimidine derivatives as the CDC25 inhibitors of phosphatases IPSEN PHARMA SAS 2010-03-31 CN disclosed
US-20100048641-A1 Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases BAYER HEALTHCARE AG LAW AND PATENTS,PATENTS AND LICENSING (DE) 2010-02-25 US disclosed
CN-101643458-A Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain VERTEX PHARMA US 2010-02-10 CN disclosed
US-7615563-B2 Compositions useful as inhibitors of voltage-gated sodium channels VERTEX PHARMACEUTICALS INCORPORATED 2009-11-10 US disclosed
WO-2009114552-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2009-09-17 WO disclosed
CN-101466692-A Thiazol-guanidine derivatives useful as a (beta) - related pathologies ASTRAZENECA AB (SE) 2009-06-24 CN disclosed
EP-1653961-A4 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORP (US) 2009-04-01 EP disclosed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US disclosed
EP-2010508-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES AstraZeneca AB (SE) 2009-01-07 EP disclosed
US-20080269300-A1 Substituted Phenylaminothiazoles and Use Thereof BAYER HEALTHCARE AG (DE) 2008-10-30 US disclosed
US-20080255143-A1 Inhibitors of Akt Activity SMITHKLINE BEECHAM CORPORATION (PA) 2008-10-16 US disclosed
CN-100422179-C 2-amino-5-benzoylthiazole npy antagonists HOFFMANN LA ROCHE (CH) 2008-10-01 CN disclosed
US-20080227895-A1 Fire retardant vinyl chloride-based resin composition and molded article thereof MITSUBISHI PLASTICS, INC. (JP) 2008-09-18 US disclosed
WO-2008066576-A2 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF THE GENERAL HOSPITAL CORPORATION (US) 2008-06-05 WO disclosed
CN-100360932-C Reagent for detecting mercury ion in water and its preparation method UNIV XIAMEN (CN) 2008-01-09 CN disclosed
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2008-01-03 US disclosed
EP-1658288-B1 2-AMINO-5-BENZOYLTHIAZOLE NPY ANTAGONISTS HOFFMANN LA ROCHE (CH) 2007-12-05 EP disclosed
WO-2007120096-A1 THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES ASTRAZENECA AB (SE) 2007-10-25 WO disclosed
EP-1709019-B1 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS (AN) 2007-08-08 EP disclosed
US-7250431-B2 neuropeptide Y(NPY) receptor antagonists; useful in the treatment of obesity; such as 4-methoxy-N-{4-[5-(2-methyl-benzoyl)-thiazol-2-ylamino]-phenyl}-benzenesulfonamide HOFFMANN-LA ROCHE INC. (US) 2007-07-31 US disclosed
CN-1926121-A Thiazole derivatives and uses thereof APPLIED RESEARCH SYSTEMS (AN) 2007-03-07 CN disclosed
US-20070040151-A1 Two-component initiator system (amine-free) with very good storage stability and particular suitability for acid systems HERAEUS KULZER GMBH (DE) 2007-02-22 US disclosed
US-20070010671-A1 Novel quinazoline derivatives and methods of treatment related to the use thereof ARENA PHARMACEUTICALS, INC. 2007-01-11 US disclosed
CN-1863785-A Heteroarylaminosulfonylphenyl derivatives useful as sodium or calcium channel blockers in the treatment of pain VERTEX PHARMA (US) 2006-11-15 CN disclosed
CN-1852907-A 2-amino-5-benzoylthiazole npy antagonists HOFFMANN LA ROCHE (CH) 2006-10-25 CN disclosed
EP-1709019-A2 THIAZOLE DERIVATIVES AND USE THEREOF Applied Research Systems ARS Holding N.V. (AN) 2006-10-11 EP disclosed
EP-1673357-A2 HETEROARYLAMINOSULFONYLPHENYL DERIVATIVES FOR USE AS SODIUM OR CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-06-28 EP disclosed
EP-1658288-A1 2-AMINO-5-BENZOYLTHIAZOLE NPY ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2006-05-24 EP disclosed
EP-1653961-A1 INHIBITORS OF AKT ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2006-05-10 EP disclosed
CN-1752750-A Reagent for detecting mercury ion in water and its preparation method UNIV XIAMEN (CN) 2006-03-29 CN disclosed
US-20060025415-A1 Compositions useful as inhibitors of voltage-gated sodium channels VERTEX PHARMACEUTICALS INCORPORATED 2006-02-02 US disclosed
US-20060014874-A1 Flame-resistant vinyl chlorride based resin composition and formed product therefrom MITSUBISHI PLASTICS, INC. (JP) 2006-01-19 US disclosed
US-6967205-B1 Compounds with antibacterial and antiparasitic properties NEW PHARMA RESEARCH SWEDEN AB (SE) 2005-11-22 US disclosed
WO-2005068444-A2 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-07-28 WO disclosed
US-20050137190-A1 Compositions useful as inhibitors of voltage-gated sodium channels VERTEX PHARMACEUTICALS INCORPORATED 2005-06-23 US disclosed
US-20050038089-A1 neuropeptide Y(NPY) receptor antagonists; useful in the treatment of obesity; such as 4-methoxy-N-{4-[5-(2-methyl-benzoyl)-thiazol-2-ylamino]-phenyl}-benzenesulfonamide HOFFMAN-LA ROCHE INC. 2005-02-17 US disclosed
WO-2005013914-A2 HETEROARYLAMINOSULFONYLPHENYL DERIVATIVES FOR USE AS SODIUM OR CALCIUM CHANNEL BLOCKERS IN THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-02-17 WO disclosed
WO-2005014592-A1 2-AMINO-5-BENZOYLTHIAZOLE NPY ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-02-17 WO disclosed
WO-2005011700-A1 INHIBITORS OF Akt ACTIVITY SMITHKLINE BEECHAM CORPORATION (US) 2005-02-10 WO disclosed
EP-1085009-B1 INDAN DERIVATIVES NISSAN CHEMICAL IND LTD (JP) 2004-11-10 EP disclosed
EP-1467981-A1 4(HETERO-) ARYL SUBSTITUTED (THIA-/OXA-/PYRA) ZOLES FOR INHIBITION OF TIE-2 Kylix Pharmaceuticals B.V. (NL) 2004-10-20 EP disclosed
US-20030158199-A1 Novel compounds for inhibition of Tie-2 KYLIX, B.V. (NL) 2003-08-21 US disclosed
WO-2003062215-A1 4(HETERO-) ARYL SUBSTITUTED (THIA-/OXA-/PYRA) ZOLES FOR INHIBITION OF TIE-2 KYLIX PHARMACEUTICALS B.V. (NL) 2003-07-31 WO disclosed
EP-0934296-B1 CHROMAN DERIVATIVES NISSAN CHEMICAL IND LTD (JP) 2003-06-04 EP disclosed
US-6486178-B1 Indane derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2002-11-26 US disclosed
EP-1085009-A1 INDAN DERIVATIVES Nissan Chemical Industries, Ltd. (JP) 2001-03-21 EP disclosed
CN-1054803-C Polycarbonic acid ester resin layered products absorbing near-infrared and formed products made of same DAICEL CHEM (JP) 2000-07-26 CN disclosed
US-6066631-A Chroman derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2000-05-23 US disclosed
WO-2000012492-A1 BENZOXAZINE DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-09 WO disclosed
EP-0934296-A1 CHROMAN DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1999-08-11 EP disclosed
WO-1998004542-A1 CHROMAN DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1998-02-05 WO disclosed
CN-1035253-C Pyranyl cyanoguanidine derivatives SQUIBB & SONS INC (US) 1997-06-25 CN disclosed
US-5514740-A SHEET OR FILM HAVING CUPRIC SULFIDE DISPERSED THEREIN DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1996-05-07 US disclosed
EP-0282971-B1 Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents WARNER LAMBERT CO (US) 1994-12-28 EP disclosed
CN-1094354-A Polycarbonate-based resin laminate of absorption near infrared ray and formed body thereof DAICEL CHEM (JP) 1994-11-02 CN disclosed
CN-1064272-A PYRANYL CYANOGUANIDINE DERIVATIVES SQUIBB & SONS INC (US) 1992-09-09 CN disclosed
US-4971983-A Use as anesthetics in surgery where a risk of cerebrovascular damage exists; e.g. riluzole WARNER-LAMBERT COMPANY (US) 1990-11-20 US disclosed
US-4918090-A ADMINISTERING TO STROKE PATIENT WARNER-LAMBERT COMPANY (US) 1990-04-17 US disclosed
US-4826860-A STROKES WARNER-LAMBERT COMPANY (US) 1989-05-02 US disclosed
EP-0282971-A2 Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents WARNER-LAMBERT COMPANY (US) 1988-09-21 EP disclosed
US-4719304-A CYCLIZATION, BROMINE CATALYST HOECHST AKTIENGESELLSCHAFT (DE) 1988-01-12 US disclosed
US-4665083-A ANTIDEPRESSANT, ANTIEPILEPTIC, SPASMOLYTIC, ANTIPARKINSONIC EGIS GYOGYSZERGYAR (HU) 1987-05-12 US disclosed
US-4363913-A Preparation of 2-aminobenzothiazoles EASTMAN KODAK COMPANY (US) 1982-12-14 US disclosed
US-4363913-A Preparation of 2-aminobenzothiazoles EASTMAN KODAK COMPANY (US) 1982-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (25 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048641-A1 Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases ADORA1, ADORA2B, ADORA2A ALDH1A1 312/4885SMN1; SMN2 4135/4885MEN1 853/4885
US-20030158199-A1 Novel compounds for inhibition of Tie-2 TIE1, TEK, KDR ALDH1A1 1890/4885SMN1; SMN2 4623/4885MEN1 839/4885
US-20240075015-A1 Inhibitors of Lysyl Oxidases LOXL1, LOXL2, LOXL4 ALDH1A1 756/4885SMN1; SMN2 1642/4885MEN1 4801/4885
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF PF4, TEC, PDGFRB ALDH1A1 234/4885SMN1; SMN2 4287/4885MEN1 1164/4885
US-20120238578-A1 COMPOSITIONS USEFUL AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS SCNN1G, KCNN3, KCNN2 ALDH1A1 2811/4885SMN1; SMN2 524/4885MEN1 2329/4885
US-20100298340-A1 Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies GRN, MAPT, GUCY1B1 ALDH1A1 1302/4885SMN1; SMN2 96/4885MEN1 3257/4885
US-20100087479-A1 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels SCNN1G, KCNN3, KCNN2 ALDH1A1 2811/4885SMN1; SMN2 524/4885MEN1 2329/4885
US-20080269300-A1 Substituted Phenylaminothiazoles and Use Thereof PAH, TNNT2, VHL ALDH1A1 739/4885SMN1; SMN2 4331/4885MEN1 2732/4885
US-20110105436-A1 HETEROARYL COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IN CANCER TREATMENT VHL, TP53, BECN1 ALDH1A1 1737/4885SMN1; SMN2 2531/4885MEN1 3092/4885
US-20050137190-A1 Compositions useful as inhibitors of voltage-gated sodium channels SCNN1G, KCNN3, KCNN2 ALDH1A1 2811/4885SMN1; SMN2 524/4885MEN1 2329/4885
US-20220378753-A1 NOVEL INHIBITORS OF LYSYL OXIDASES LOXL1, LOXL2, LOXL4 ALDH1A1 1028/4885SMN1; SMN2 1679/4885MEN1 4832/4885
US-20150197501-A1 Process for Preparing Episulfide Compounds TST, EPHX2, STS ALDH1A1 405/4885SMN1; SMN2 3397/4885MEN1 3754/4885
US-20070010671-A1 Novel quinazoline derivatives and methods of treatment related to the use thereof MCHR1, GPR119, MCHR2 ALDH1A1 2069/4885SMN1; SMN2 1509/4885MEN1 647/4885
US-20080255143-A1 Inhibitors of Akt Activity PI4KB, PIK3CA, AKT2 ALDH1A1 4166/4885SMN1; SMN2 3299/4885MEN1 3151/4885
US-20060025415-A1 Compositions useful as inhibitors of voltage-gated sodium channels SCNN1G, KCNN3, KCNN2 ALDH1A1 2811/4885SMN1; SMN2 524/4885MEN1 2329/4885
US-20170020900-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF ZC3HAV1, MAVS, EIF2AK2 ALDH1A1 3829/4885SMN1; SMN2 3747/4885MEN1 4593/4885
US-20090029998-A1 Thiazole Derivatives and Use Thereof PDGFRB, PDGFRA, TEC ALDH1A1 174/4885SMN1; SMN2 1799/4885MEN1 1761/4885
US-20130184258-A1 Compositions Useful as Inhibitors of Voltage-Gated Sodium Channels SCNN1G, KCNN3, KCNN2 ALDH1A1 2811/4885SMN1; SMN2 524/4885MEN1 2329/4885
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use INCENP, CYBA, ADCY5 ALDH1A1 371/4885SMN1; SMN2 4522/4885MEN1 4480/4885
US-20050038089-A1 neuropeptide Y(NPY) receptor antagonists; useful in the treatment of obesity; such as 4-methoxy-N-{4-[5-(2-methyl-benzoyl)-thiazol-2-ylamino]-phenyl}-benzenesulfonamide NPY5R, NPY1R, NPY4R ALDH1A1 3138/4885SMN1; SMN2 2958/4885MEN1 1824/4885
US-11712437-B2 Inhibitors of lysyl oxidases LOXL1, LOXL2, LOXL4 ALDH1A1 864/4885SMN1; SMN2 1726/4885MEN1 4808/4885
US-11993573-B2 Chromane-substituted, tetrahydroquinoline-substituted and thiochromane-substituted heteroarotinoids as anti-cancer agents HCCS, CDYL, CDYL2 ALDH1A1 3983/4885SMN1; SMN2 4516/4885MEN1 2252/4885
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use INCENP, CYBA, PAICS ALDH1A1 378/4885SMN1; SMN2 4430/4885MEN1 4473/4885
US-20140107350-A1 Process for Preparing Episulfide Compounds TST, EPHX2, STS ALDH1A1 405/4885SMN1; SMN2 3397/4885MEN1 3754/4885
US-20100216852-A1 METHODS FOR SCREENING ANTIMICROBIAL AND ANTIVIRAL COMPOUNDS AND USES THEREOF ZC3HAV1, MAVS, EIF2AK2 ALDH1A1 3829/4885SMN1; SMN2 3747/4885MEN1 4593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.